SG Finserve Ltd
SGFINSG Finserve Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +75.8% in a year while annual EPS moved +35.0% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (23 weeks in) while the P/BV sits at the 63rd percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +116.0% year on year, with the the net margin at 39.7%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
SG Finserve Ltd trades at ₹661, in a confirmed uptrend and 23 weeks into that stage. That is +19.6% against its own 200-day average. It sits at 90% of a 52-week range of ₹333 to ₹699. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 33 straight weeks.
Today the stock is in a confirmed uptrend — week 23 of stage 2, confirmed. At ₹661 it trades +19.6% versus its 200-day average and sits at 90% of its 52-week range (₹333–₹699).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +4,761% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 33 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
SG Finserve Ltd's story is not scored yet against the markers our research file set on 19 July 2026. Where it sits in its own cycle: MID_EXPANSION. Our fortnightly research layers last read it on 22 August 2026.
Our read, 19 July 2026. Capital-efficient supply chain NBFC compounding AUM at 80%+ YoY with zero NPAs; Q1 FY27 PBT of Rs 72 Cr (27% QoQ) signals inflection toward the guided Rs 300 Cr FY27 PBT — leverage expansion from 2.2x to 3x is the ROE re-rating engine, but five documented guidance reversals cap conviction.
From the numbers. P/BV at 75th percentile (2.95x vs 1.15x historical median, 2.565x ratio to median) — above median and now expanding QoQ after a contraction phase. The cycle is in mid-expansion. For a lender, P/BV is the primary…
From the price. Price stage 2, week 23 — above its 200-day line, relative strength falling.
From the research. Capital-efficient supply chain NBFC compounding AUM at 80%+ YoY with zero NPAs; Q1 FY27 PBT of Rs 72 Cr (27% QoQ) signals inflection toward the guided Rs 300 Cr FY27 PBT — leverage expansion from 2.2x to 3x is the ROE…
🚨 Where they disagree. P/BV at 75th percentile (2.95x vs 1.15x historical median, 2.565x ratio to median) — above median and now expanding QoQ after a contraction phase. The cycle is in mid-expansion. For a lender, P/BV is the primary valuation lens (PE is not meaningful given the financial structure). At current ROE 10%, a 2.95x P/BV implies the market prices ROE re-rating to approximately 15% (justified P/BV = ROE/COE; at 14% COE and 15% ROE, fair P/BV is 1.07x — the gap to 2.95x reflects growth optionality and zero-NPA franchise premium). The two-level read: the 75th percentile P/BV is NOT expensive — it is growth-optionality premium on a lender with 80%+ AUM CAGR and nil NPAs that ROE is structurally rising…
What is proven. Capital-efficient supply chain NBFC compounding AUM at 80%+ YoY with zero NPAs; Q1 FY27 PBT of Rs 72 Cr (27% QoQ) signals inflection toward the guided Rs 300 Cr FY27 PBT — leverage expansion from 2.2x to 3x is the ROE re-rating engine, but five documented guidance reversals cap conviction.
What is not proven yet. Any non-zero NPA in the Q2 or Q3 FY27 book, OR a third consecutive absolute-AUM guide downgrade (Jul 2026 guide Rs 5500 Cr by year-end) after the Oct 2025 Rs 6000 Cr → Apr 2026 Rs 5300-5510 Cr downgrade sequence, would break the thesis — the zero-NPA premium and the compounding guidance credibility are the two pillars; if either cracks, the justified P/BV drops from 3x toward 1.5x.
🚨 What would change our mind. Any non-zero NPA in the Q2 or Q3 FY27 book, OR a third consecutive absolute-AUM guide downgrade (Jul 2026 guide Rs 5500 Cr by year-end) after the Oct 2025 Rs 6000 Cr → Apr 2026 Rs 5300-5510 Cr downgrade sequence, would break the thesis — the zero-NPA premium and the compounding guidance credibility are the two pillars; if either cracks, the justified P/BV drops from 3x toward 1.5x.
🚨 Layer 1 read, 22 August 2026 — DROP. Zero bad loans and profit up 116% — but you pay 3x book for a business still earning only 10% on equity. The lending model is genuinely different: the company pays the dealer supplier directly and cuts off further supply until repayment, which is why Rs 52,000 crore has gone out with no defaults, and quarterly profit has stepped up Rs 25, 28, 32, 42, 54 crore. The re-rating case is honest arithmetic — borrowing more against a 32% capital cushion mechanically lifts return on equity from 10% to 14-16% — but the shares already charge 3.07x book value for it, against a level the timeline own model puts nearer 0.71x on today returns. Two things hold me back: the profit account has never once carried a bad-loan charge, so returns are flattered by a cost that will eventually appear, and management…
What would change Layer 1’s mind. Sharpening the timeline own test with what the chief executive would not promise: the first non-zero bad-loan number in the September or December 2026 book flips this immediately, because the entire premium rests on a record management has itself refused to guarantee ("I am not certain of that", "accidents or losses may occur") — and with no provisioning history there is no cushion in the profit account to absorb it. The second flip is a March-2027 leverage reading still stuck at or below 2.2x…
The test written in advance. NPA emergence as book seasons — thesis-killer risk — NPA emergence as book seasons — thesis-killer risk Quarterly NPA percentage: any non-zero GNPA figure in Q2 or Q3 FY27 results. by the next result.
The test written in advance. Management communication — sixth reversal deepens credibility deficit — Management communication — sixth reversal deepens credibility deficit by the next result.
What the company does. SG Finserve fills the working capital gap in anchor-dealer supply chains (tripartite enforcement: direct-to-anchor payment, stop-supply on default), achieving zero NPA across Rs 52000+ Cr cumulative disbursements. Q1 FY27 delivered PBT of Rs 72 Cr (82% YoY AUM growth, nil NPAs, ROA 5.1%) and management now guides Rs 300 Cr FY27 PBT — 75% YoY growth. The ROE re-rating thesis (current 10% → target 14-16%) depends on leverage moving from 2.2x to 3x without credit quality deterioration, while a factoring platform (Rs 225 Cr AUM) opens a second revenue layer.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| AUM compounding at 80%+ YoY with improving… | in play | — | AUM Rs 4552 Cr (Jun 2026, 82% YoY); management targets Rs 5500 Cr by FY27 exit (25% QoQ pace); 52 anchor mandates with Rs 7700… | APL Apollo or a major anchor group faces a balance-sheet event, causing dealers to stop procuring, which would dry up the disbursement pipeline at… |
| Leverage expansion from 2.2x to 3x — the… | in play | — | ROE moves from 10% to 14-16% mechanically as leverage expands from 2.2x to 3x while maintaining ROA at 5%; no equity dilution… | ROA compresses below 4.5% (the guided floor) due to higher cost of funds or provision charges, making the ROE gain from leverage insufficient to… |
| Factoring platform: second revenue lane… | in play | — | Factoring AUM Rs 225 Cr (Jun 2026, up from Rs 175 Cr at March launch); 12.5% yield maintained; bilateral and TReDS both… | Any non-zero NPA in the Q2 or Q3 FY27 book, OR a third consecutive absolute-AUM guide downgrade (Jul 2026 guide Rs 5500 Cr by year-end) after the… |
| Promoter re-concentration — warrant… | in play | — | Promoter shareholding increased from 48.38% (Sep 2025) to 52.92% (Mar 2026) to 56.95% (Jun 2026) — an 8.57pp increase in two… | Promoter pledging emerges against the newly converted shares, converting the concentration signal from positive (alignment) to negative (collateral… |
🚨 What the surface reading misses. The surface reading is: 75th percentile P/BV — above median, potentially expensive on a cycle basis The research reads it further: For a lender with 80%+ AUM CAGR and nil NPAs, P/BV above median is the market pricing in the ROE re-rating from 10% to 14-16% that is mechanically in progress. The 2.95x P/BV is a growth option, not a cycle-expensive multiple — the price-to-book premium reflects expected future book value growth, not an overshoot of current fundamentals.
🚨 What the surface reading misses. The surface reading is: ROE 9-10% in FY25-26 is below comparable NBFCs trading at 15%+ ROE — suggests subpar returns The research reads it further: ROE of 9-10% is structurally depressed by underleveraging, not by business quality weakness. With equity Rs 1539 Cr and leverage only 2.2x, the NBFC's assets are underfunded relative to its capital base. ROA of 5.1% (Q1 FY27) is exceptional for any NBFC — the only reason ROE is low is the deliberate equity-first growth phase (Rs 1100 Cr → Rs 1539 Cr equity through retained earnings and warrant conversions). As leverage moves toward 3x on this ROA, ROE mechanically reaches 15%. The weak ROE is the setup, not the problem.
Lever 12 · New product launch — BUILDING. AUM Rs 4552 Cr (Jun 2026, 82% YoY); management targets Rs 5500 Cr by FY27 exit (25% QoQ pace); 52 anchor mandates with Rs 7700 Cr MOU value underpin the pipeline. What proves it keeps working: AUM compounding at 80%+ YoY with improving per-quarter run rate. It stops working if APL Apollo or a major anchor group faces a balance-sheet event, causing dealers to stop procuring, which would dry up the disbursement pipeline at the source rather than the credit end.
Sources: our stock research file (19 July 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
| Section | Where it is now | Vs a year ago | The one thing to watch next | Read |
|---|---|---|---|---|
| Loan book | see the section | — | AUM compounding at 80%+ YoY with improving per-quarter run… | |
| Debt | see the section | — | Leverage expansion from 2.2x to 3x — the ROE re-rating… | |
| Revenue | ₹75 Cr | — | Factoring platform: second revenue lane within the same… | |
| Ownership | see the section | — | Promoter re-concentration — warrant conversion drives… |
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
SG Finserve Ltd reported ₹136 Cr of income in the Jun 26 quarter, +100.0% year on year. That is the 5th straight quarter of year-on-year growth. Over 10 years it has compounded at 55.7% a year. The last full year, FY26, came in at ₹334 Cr. The last four reported quarters add to ₹402 Cr.
Why this happened. Factoring is structurally lower-credit-risk than dealer financing — the receivable is an invoice backed by an anchor's obligation, not a dealer's ability to sell. The March 2026 launch demonstrated rapid traction: Rs 50 Cr quarterly increment in Q1 FY27, representing a 29% QoQ growth in a newly commercialized product. At a 5% penetration rate of the total AUM, the factoring book has significant runway to grow to 15-20% without altering the portfolio risk profile. Management cited fewer than 1% of Indian banks offering factoring — structural penetration tailwind.
FY26 revenue came in at ₹334 Cr (+96.5% on the year), capping 10 years at 55.7% compound. The latest quarter (Jun 26) printed ₹136 Cr, +100.0% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +110.3% growth against the decade's 55.7% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +106.2% over the last 4 quarters against +42.1%/yr over the last 8 — accelerating; TTM profit +79.3% vs +37.9%/yr — accelerating.
FY26-Q4. FY26 closes Rs 128 Cr PAT (58% YoY), AUM Rs 3936 Cr (75% YoY); factoring launches at Rs 175 Cr; FY27 guidance 35-40% AUM growth
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
SG Finserve Ltd's net margin is 39.7% in the Jun 26 quarter, +2.9 percentage points against the same quarter a year ago. Across 11 fiscal years the net margin has ranged 0.0% to 100.0%. The current quarter sits inside that band.
The latest quarter's net margin is 39.7%, +2.9 pp against the same quarter a year ago. Across 11 fiscal years the net margin has ranged 0.0%–100.0%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
FY26-Q4. FY26 closes Rs 128 Cr PAT (58% YoY), AUM Rs 3936 Cr (75% YoY); factoring launches at Rs 175 Cr; FY27 guidance 35-40% AUM growth
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
SG Finserve Ltd earned ₹54.0 Cr of net profit in the Jun 26 quarter, +116.0% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹128 Cr. That is 39.7% of the quarter's revenue. The same quarter a year earlier earned ₹25.0 Cr.
Jun 26 profit was ₹54.0 Cr, +116.0% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹128 Cr (+58.0%).
Why profit moved: revenue contributed +100.0% and the margin +2.9 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +81.1% vs revenue +110.3%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
FY26-Q4. FY26 closes Rs 128 Cr PAT (58% YoY), AUM Rs 3936 Cr (75% YoY); factoring launches at Rs 175 Cr; FY27 guidance 35-40% AUM growth
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for SG Finserve Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
SG Finserve Ltd's revenue grew +96.5% in FY26 to ₹334 Cr, so the book is growing. The latest quarter ran +100.0% year on year. The net margin on that income is 39.7%, +2.9 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
Why this happened. From Mar 2023 (Rs 100 Cr range) to Jun 2026 Rs 4552 Cr represents a 45x book build in 12 quarters, driven by anchor mandates across construction, auto, and industrial sectors. The deepening strategy (expand dealer network under existing anchors) and widening strategy (new geographies, factoring) create two independent growth engines. The tripartite model means disbursement capacity (not underwriting risk) is the bottleneck — and Rs 3000-3500 Cr of untapped bank limits as of April 2026 provides the disbursement runway for FY27 targets.
FY26 revenue was ₹334 Cr, +96.5% on the year, and the latest quarter ran +100.0% year on year. The net margin on that revenue is 39.7% this quarter (+2.9 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
SG Finserve Ltd earns a return on equity of 10% in FY26. Its trough over the ladder below was −14% in FY20. For a lender the balance sheet is the operating asset, so equity return and asset return have to be read together.
FY26 ROE came in at 10%, recovered from a FY20 trough of −14%. Return on assets is withheld on this page — its two source series disagree for this quarter. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why: the ROE ladder shows the move; the deposit-cost and provisioning drivers behind it sit below what we hold.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
Why this happened. ROE moves from 10% to 14-16% mechanically as leverage expands from 2.2x to 3x while maintaining ROA at 5%; no equity dilution needed.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 8.6 points of SG Finserve Ltd over 8 quarters, the biggest move on the register. That takes promoters to 57.0% of the company. Foreign institutions moved +0.5 points over the same window, to 0.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
Why this happened. The promoter increase from 48.38% to 56.95% is a material development not highlighted in the prior timeline (which used Sep 2025 data). Warrant conversions at Rs 450/sh, when the market price is Rs 631, represent 40% discount to market — this is not dilution at market, it is a pre-agreed conversion that adds equity to the balance sheet (Rs 20 Cr in April alone per concall) and simultaneously concentrates promoter ownership. DII ownership has compressed from 4.44% (Jun 2025) to 2.18% (Jun 2026) as public float tightened. FII at 0.54% remains minimal.
The register over the last two years — Promoters: +8.6 points over 8 quarters to 57.0%; Foreign institutions: +0.5 points over 8 quarters to 0.5%; Domestic institutions: +0.4 points over 8 quarters to 2.2%.
Why the register moved: promoters drove it (+8.6 points), alongside foreign institutions (+0.5 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
SG Finserve Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
SG Finserve Ltd trades at 3.0× P/BV, mid-range by its own standards (63rd percentile). Its long-run median P/BV is 2.6×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 3.0× is mid-range by its own standards (63rd percentile), against a long-run median of 2.6× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 10% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +75.8% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +144.4%/yr price move, ~+77.2%/yr came from book-value growth and ~+67.2 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 27 August 2026 price, SG Finserve Ltd was paying for profit growth of about 20.4% a year. Today the market pays 3.0× P/BV, the 63rd percentile of its own 11-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is the whole of what a buyer is backing.
How to hold this number: it is a reading of one day's price, taken on 27 August 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
SG Finserve Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROE at 10.7% is below the 12% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +96.5% | +101.2% | +178.3% | +55.7% |
| Profit | +58.0% | +92.3% | +129.7% | — |
| EPS | +35.0% | +63.7% | +44.1% | +59.8% |
| Share price | +75.8% | +5.2% | +144.4% | +48.0% |
4-Factor Sector Score
59.7/100 — rank 3 of 6 in Finance & Investments - MSME Lending · 82% evidence confidence
SG Finserve Ltd scores 59.7 out of 100 against the 6 companies it is compared with in Finance & Investments - MSME Lending, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 26.5 + 13.3 + 4.9 + 15 = 59.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Said versus delivered
What SG Finserve Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
New Business Initiatives Timeline Contradicted · 14 July 2026. In the Jan 2026 call, management explicitly promised that nothing material would happen with new business initiatives for 2-3 years, asking investors to mark their words. However, in the Jul 2026 call just six months later, management confirmed they have already incorporated an insurance broking subsidiary, are applying for an IRDAI license, and have obtained shareholder approval for AIF, ARC, and GIFT City operations, directly contradicting their prior commitments without acknowledging or explaining the reversal.
🚨 FY27 Absolute AUM Target Downgrade · 16 April 2026. In the October 2025 call, management explicitly set an AUM target of INR6,000 crores for FY27, predicated on an expected FY26 exit AUM of INR3,500 crores. However, in the April 2026 call, despite reporting an actual FY26 exit AUM of INR3,936 crores (higher than the prior estimate), they now aspire to "35% to 40% growth" for FY27. This revised percentage growth on the larger FY26 base yields an implied FY27 AUM range of approximately INR5,313 crores to INR5,510 crores, representing a material downgrade of the absolute FY27 AUM target from the previously guided INR6,000 crores. Earlier call (Oct 2025): “well positioned to achieve the target AUM of INR6,000 crores by FY27.” Later call (Apr 2026): “The loan book stands at 3,936 crores... Our long-term AUM growth guidance remains 25% to 30%, but for FY27, we are aspiring toward 35% to 40% growth.”
Strategic Pivot Away from New Business Verticals · 16 April 2026. In the January 2026 call, management explicitly stated that "the board has approved our expansion plan to set up four new subsidiaries" to "explore and evaluate the areas of ARC, AIF, Insurance Broking, and FinTech business." They also provided reassurance that actual investment or action on these were years away. However, in the April 2026 call, there is no mention of these previously approved or explored new subsidiaries whatsoever, indicating a pivot away from these new business verticals without explanation. Earlier call (Jan 2026): “Subject to regulatory approvals, today the board has approved our expansion plan to set up four new subsidiaries, which will further augment our fee-based revenue. Currently, it is at the drawing board stage, but the board has approved to explore and evaluate the areas of ARC, AIF, Insurance Broking, and FinTech business.” Later call (Apr 2026): “Our core focus remains supply chain, but that has multiple facets. We have been doing Tier-1 dealer financing, and we have recently started Tier-2 dealer financing as well... Factoring is another growth area that has just begun. We will also provide corporate loans, term funding, and working capital via our cross-sell business.”
Major Guidance Cut · 23 January 2026. Management materially lowered their medium-term AUM targets. While they previously guided for an AUM of INR 6,000 crores by FY27, the latest call pivots to a conservative 20% CAGR strategy, explicitly admitting the guidance is lower and projecting a linear addition of only INR 1,000 crores annually. Earlier call (Oct 2025): “We are well positioned to achieve the target AUM of INR6,000 crores by FY27.” Later call (Jan 2026): “That is the reason why this guidance looks lower compared to what we said when we started the company... every year we aim to increase it by 1,000 crores.”
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1SBFC Finance LtdSBFC | 73.3/100Favorable setup100% evidence | TURNING | 28.8/35 Income 27.6% · PAT 30.8% 100% evidence | 18.3/25 ROA 4.1% · ROE 13% · GNPA 2.7% 100% evidence | 10.6/20 P/BV 2.91× · P/BV÷ROE 0.22 100% evidence | 15.6/20 RS sector 0.8% · RS bench 1.2% · 1Y -8.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 28.8 + 18.3 + 10.6 + 15.6 = 73.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2MAS Financial Services LtdMASFIN | 63.7/100Mixed-positive evidence88% evidence | BASING | 24.8/35 Income 23.1% · PAT 21.3% 86% evidence | 15.8/25 ROA 2.7% · ROE 13.4% · GNPA — 72% evidence | 16.1/20 P/BV 1.8× · P/BV÷ROE 0.13 100% evidence | 7.0/20 RS sector -4.7% · RS bench -4% · 1Y -4.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.8 + 15.8 + 16.1 + 7 = 63.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3SG Finserve Ltdthis pageSGFIN | 59.7/100Mixed-positive evidence82% evidence | LEADER | 26.5/35 Income 100% · PAT 79.3% 86% evidence | 13.3/25 ROA 3% · ROE 10.3% · GNPA — 72% evidence | 4.9/20 P/BV 2.95× · P/BV÷ROE 0.29 70% evidence | 15.0/20 RS sector 35.6% · RS bench 36.4% · 1Y 75.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.5 + 13.3 + 4.9 + 15 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Five-Star Business Finance LtdFIVESTAR | 44.3/100Mixed-negative evidence94% evidence | BREAKING OUT | 3.4/35 Income 9.8% · PAT 1.5% 100% evidence | 20.8/25 ROA 7% · ROE 16.1% · GNPA 3.5% 100% evidence | 11.6/20 P/BV 2.2× · P/BV÷ROE 0.14 100% evidence | 8.5/20 RS sector -21.2% · RS bench 10.7% · 1Y 3.5%10 of 10 weeks ahead 70% evidence |
| Exact sum: 3.4 + 20.8 + 11.6 + 8.5 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Ugro Capital LtdUGROCAP | 38.5/100Thin evidence · provisional55% evidence | ASLEEP | 16.5/35 Income — · PAT — 11% evidence | 9.8/25 ROA 1.5% · ROE 6% · GNPA — 68% evidence | 8.6/20 P/BV 0.45× · P/BV÷ROE 0.07 70% evidence | 3.6/20 RS sector -33.2% · RS bench -33.2% · 1Y -53.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 9.8 + 8.6 + 3.6 = 38.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Moneyboxx Finance LtdMONEYBOXX | 27.3/100Adverse evidence67% evidence | 16.5/35 Income 16.5% · PAT 8.1% 29% evidence | 4.6/25 ROA 0.1% · ROE 0.5% · GNPA — 68% evidence | 3.2/20 P/BV 1.43× · P/BV÷ROE 2.98 100% evidence | 3.0/20 RS sector -13.4% · RS bench -14% · 1Y -13.3%0 of 4 weeks ahead to 2026-07-19 100% evidence | |
| Exact sum: 16.5 + 4.6 + 3.2 + 3 = 27.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is SG Finserve Ltd's share price today?
SG Finserve Ltd trades at ₹661, +75.8% over the past year. The company is valued at ₹4,354 Cr. The stock sits at 90% of its 52-week range of ₹333–₹699, +19.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 23 weeks in. — as of 11 September 2026.
What were SG Finserve Ltd's latest quarterly results?
SG Finserve Ltd reported total income of ₹136 Cr and net profit of ₹54.0 Cr for the Jun 26 quarter. Income rose 100.0% and profit rose 116.0% year on year. Earnings per share were ₹8.15. The net margin was 39.7%, 2.9 pp higher than a year earlier. — as of 11 September 2026.
What is SG Finserve Ltd's revenue?
SG Finserve Ltd reported revenue of ₹136 Cr in the Jun 26 quarter, +100.0% year on year. For the full FY26 fiscal year, revenue was ₹334 Cr (+96.5%). Over the last 10 years revenue compounded at 55.7% a year. — as of 11 September 2026.
What is SG Finserve Ltd's profit?
SG Finserve Ltd earned ₹54.0 Cr of net profit in the Jun 26 quarter, +116.0% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹128 Cr. The net margin ran 39.7% in the latest quarter. — as of 11 September 2026.
What is SG Finserve Ltd's market cap?
SG Finserve Ltd's market capitalisation is ₹4,354 Cr at a share price of ₹661. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is SG Finserve Ltd's P/BV ratio?
SG Finserve Ltd trades at a P/BV of 3.0×, at the 63rd percentile of its own 11-year range, against a long-run median of 2.6×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does SG Finserve Ltd pay a dividend?
No — SG Finserve Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is SG Finserve Ltd overvalued?
On its own history, SG Finserve Ltd looks mid-range: its P/BV of 3.0× sits at the 63rd percentile of its 11-year range (long-run median 2.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is SG Finserve Ltd growing?
Yes — SG Finserve Ltd is growing: latest-quarter revenue +100.0% year on year, profit +116.0%, and the net margin +2.9 pp at 39.7%. The earnings engine currently reads: improving — as of 11 September 2026.
How is SG Finserve Ltd performing?
SG Finserve Ltd is in a confirmed uptrend, 23 weeks in. Its latest quarter's income rose 100.0% and profit rose 116.0% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 33 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is SG Finserve Ltd in?
Mixed — the growth curves are steadily positive, but ROE at 10.7% is below the 12% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +106.2% latest, profit growth +79.3% latest, eps growth +65.5% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is SG Finserve Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 23 of stage 2), trading +19.6% versus its 200-day average and at 90% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is SG Finserve Ltd beating the market?
On recent form, yes — SG Finserve Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 33 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +4,761% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will SG Finserve Ltd's share price go up?
This page publishes no price forecast for SG Finserve Ltd. What it measures instead: the share price is ₹661, the price is in a confirmed uptrend 23 weeks in. Its P/BV of 3.0× sits at the 63rd percentile of its own 11-year range. — as of 11 September 2026.
Who owns SG Finserve Ltd?
Promoters hold 57.0% of SG Finserve Ltd, foreign institutions 0.5%, domestic institutions 2.2% and the public 40.3% (latest quarter). The biggest move on the register over the last two years: Promoters added 8.6 points over 8 quarters. — as of 11 September 2026.
Where is SG Finserve Ltd in its business cycle?
SG Finserve Ltd's FY26 net margin was 38.3%, against a 11-year band of 0.0%–100.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 39.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does SG Finserve Ltd's price assume?
At its price on 27 August 2026, SG Finserve Ltd was priced for profit growth of about 20.4% a year. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the SG Finserve Ltd story?
The sharpest disagreement: the price moved +75.8% in a year while annual EPS moved +35.0% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is SG Finserve Ltd a stock worth studying right now?
This is not investment advice. The machine read: SG Finserve Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!